Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ALZN - Alzamend Neuro, Inc.
Market Cap 44.50M P/E - EPS this Y 35.60% Ern Qtrly Grth -
Income -12.4M Forward P/E -2.09 EPS next Y 0.70% 50D Avg Chg -20.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -33.00%
Dividend N/A Price/Book 14.81 EPS next 5Y - 52W High Chg -69.00%
Recommedations 2.50 Quick Ratio 0.07 Shares Outstanding 6.87M 52W Low Chg 48.00%
Insider Own 29.64% ROA -166.84% Shares Float 4.83M Beta 0.02
Inst Own 5.45% ROE -1,196.26% Shares Shorted/Prior 14.51K/51.22K Price 0.46
Gross Margin - Profit Margin - Avg. Volume 159,893 Target Price 21.00
Oper. Margin - Earnings Date - Volume 76,803 Change 0.50%
Healthcare | Biotechnology | United States
About Alzamend Neuro, Inc.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Alzamend Neuro, Inc. News
04/02/24 Insiders Are Buying These 11 Penny Stocks
12/11/23 EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year
12/11/23 Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients
11/20/23 Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients
11/16/23 Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
11/13/23 Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001
10/30/23 Alzamend Neuro Announces Reverse Stock Split
10/23/23 EXCLUSIVE: Alzamend Neuro Submits IND For Phase IIA Trial Of Next-Gen Lithium Candidate In Major Depressive Disorder
10/23/23 Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Major Depressive Disorder Patients of its Next‑Generation Lithium Therapeutic Drug Candidate AL001
10/02/23 EXCLUSIVE: Alzamend Neuro To Start Next-Gen Therapy Study For Bipolar Disorder
10/02/23 Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Bipolar Disorder Patients
09/22/23 Alzamend Neuro Granted Extension by Nasdaq Panel to Regain Compliance with the Minimum Bid Price Continued Listing Requirement
08/30/23 EXCLUSIVE: Alzamend Seeks FDA Approval For Study For Upgraded Version Of Most Commonly Used Treatment For Bipolar Disorder
08/30/23 Alzamend Neuro Submits IND Application for Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Bipolar Disorder Patients
08/24/23 We're A Little Worried About Alzamend Neuro's (NASDAQ:ALZN) Cash Burn Rate
06/22/23 EXCLUSIVE: Alzamend Neuro Identifies Potential AL001 Dose Level For Upcoming Alzheimer's Study
06/22/23 Alzamend Neuro Announces Positive Phase IIA Clinical Trial Results for AL001
06/13/23 Alzamend Neuro CEO Stephan Jackman to Participate on the "Mental Health, More Critical Than Ever" Panel at the Maxim Group’s Virtual Healthcare Conference
05/24/23 3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024
05/11/23 3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year
ALZN Chatroom

User Image AntoineChigurh Posted - 14 hours ago

$ALZN when’s the next reverse split?

User Image insiderbuyingselling Posted - 2 days ago

$ALZN new insider buying: 1000 shares. http://insiderbuyingselling.com/?t=ALZN

User Image StocksMilkShake Posted - 2 days ago

$ALZN I think offering is coming.

User Image StocksMilkShake Posted - 3 days ago

$ALZN BUY 😁✌

User Image stefangl Posted - 3 days ago

$ALZN the pipeline is good, with good results, I don’t understand why this stock is so cheap

User Image StocksMilkShake Posted - 5 days ago

$ALZN Delist to OTC?

User Image MsKellyKapowski Posted - 1 week ago

$ALZN another reverse split should convince all the bagholders they made a very big mistake. You got Miltoned ! 👠💄🍒

User Image Scrood_the_Pooch Posted - 1 week ago

$AULT $ALZN $ROII Amazing! Two days in a row X 3 companies rocking all time lows. Killing it Jabba!

User Image citroengirl Posted - 1 week ago

$ALZN I am just waiting for a miracle here 🙄

User Image Scrood_the_Pooch Posted - 1 week ago

$AULT $ALZN $ROII Yay! Hat Trick!

User Image Scrood_the_Pooch Posted - 1 week ago

Big Shout Out to are sister companies $ALZN and $ROII on their brand new All Time Lows today! Will $AULT make it a hat trick? It's trying!

User Image LG1207 Posted - 1 week ago

$ALZN ..have no position here anymore. Lost my ass and sold this pos. But I check back every once in a while. 78 cents? Wow. I feel sorry for people holding this.

User Image Fuddsblood65 Posted - 1 week ago

$ALZN Another in a long line of Ault success stories!

User Image JRP07 Posted - 1 week ago

$ALZN nothing but scam company ! 💩😷

User Image simoncada Posted - 2 weeks ago

This week begins in green $ALZN , $SINT and $OPK, waiting for this three to go up more.

User Image Earth4thewin Posted - 2 weeks ago

$ALZN thanks Stephan Jackman 🙄

User Image ASM Posted - 2 weeks ago

INCREDIBLE $spy $qqq $nvda $alzn $meta

User Image Greba1971 Posted - 3 weeks ago

$ALZN another rs…junk

User Image Earth4thewin Posted - 3 weeks ago

$ALZN hope you voted against all of the boards recommendations, especially the reverse split ✅

User Image AntoineChigurh Posted - 03/28/24

$ALZN biggest pos in the ‘biotech’ mkt. and the biggest pos, just in general.

User Image The_Grim_Reaper Posted - 03/26/24

$ALZN You lucky buggers are going to get another 1:20 reverse split! YAY! But what is this $283K in cash and $4.5M in liabilities? How does that work? Dilute and RS, dilute and RS. Good old Mr. Jabba hard at work.

User Image Fuddsblood65 Posted - 1 month ago

$ALZN Todd is re-opening the ATM here at Alzn! Can't proceed as a going concern blah blah blah

User Image Tshanky_ Posted - 1 month ago

$ALZN “We are advancing the process and expect that the first patient will be dosed in the first quarter of 2024.” No news on this yet right?

User Image LG1207 Posted - 1 month ago

$ALZN ..I lost so much money on this. Bought in at $5 and watched it slow trickle down to cents. And they did a reverse stock split, taking most of my stock. The wost investment I ever made. Alzn sucks ass

User Image engaziz14181997 Posted - 1 month ago

$ALZN Gravestone Doji Candle 👍🏻

User Image Greba1971 Posted - 1 month ago

$ALZN scam ,junk…delist

User Image FyCkD_FuNnY Posted - 1 month ago

$ALZN $ROI $MICS $AULT @Loan2Buy

User Image AntoineChigurh Posted - 1 month ago

$ALZN yeah it’s GORGEOUS!!!!

User Image StockMET Posted - 1 month ago

$ALZN beautiful chart 📈

User Image Swingita Posted - 1 month ago

$ALZN This will come back down to $0.96 before going $2+. Technical analysis, that's all.

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Katzoff David J Chief Financial Offi.. Chief Financial Officer Sep 26 Buy 0.1931 53,000 10,234 81,000 09/26/23
AULT MILTON C III Director Director May 24 Buy 0.5947 18,000 10,705 383,000 05/26/23
AULT MILTON C III Director Director Feb 15 Buy 0.5973 1,000 597 11,051,001 02/17/23
AULT MILTON C III Director Director Dec 27 Buy 0.58 4,000 2,320 11,050,001 12/29/22
Jackman Stephan Chief Executive Offi.. Chief Executive Officer Sep 19 Buy 1.2252 8,500 10,414 8,500 09/20/22
AULT MILTON C III Director Director Aug 16 Buy 1.0809 15,000 16,214 9,966,667 08/18/22
AULT MILTON C III Director Director Aug 15 Buy 1.0595 14,000 14,833 9,951,667 08/16/22
AULT MILTON C III Director Director Aug 12 Buy 1.04 1,000 1,040 9,937,667 08/15/22
AULT MILTON C III Director Director Jul 27 Buy 0.87 5,700 4,959 9,934,667 07/28/22
AULT MILTON C III Director Director Jul 22 Buy 0.9051 2,300 2,082 9,928,967 07/25/22
AULT MILTON C III Director Director Jul 18 Buy 0.9773 10,000 9,773 9,926,667 07/19/22
AULT MILTON C III Director Director Jun 29 Buy 0.8830 10,000 8,830 9,916,667 06/30/22
AULT MILTON C III Director Director Jun 17 Buy 0.8841 10,000 8,841 9,906,667 06/21/22
AULT MILTON C III Director Director Jun 15 Buy 0.8740 10,000 8,740 9,896,667 06/16/22
AULT MILTON C III Director Director Jun 14 Buy 0.8474 10,000 8,474 9,886,667 06/15/22
AULT MILTON C III Director Director Jun 08 Buy 0.9470 8,000 7,576 9,876,667 06/09/22
AULT MILTON C III Director Director Jun 02 Buy 0.9599 8,000 7,679 9,866,667 06/03/22
AULT MILTON C III Director Director May 26 Buy 0.94 22,000 20,680 9,858,667 05/31/22
AULT MILTON C III Director Director May 24 Buy 0.8886 16,100 14,306 9,836,667 05/26/22
AULT MILTON C III Director Director May 17 Buy 0.98 23,900 23,422 9,815,567 05/18/22
AULT MILTON C III Director Director May 06 Buy 0.93 125,000 116,250 9,791,667 05/13/22
AULT MILTON C III Director Director May 05 Buy 1.0685 100,000 106,850 325,000 05/06/22
AULT MILTON C III Director Director Apr 26 Buy 1.50 2,666,667 4,000,000 9,666,667 04/28/22
Horne William B. Director Director Apr 26 Option 0.0004 250,000 100 500,000 04/28/22
AULT MILTON C III Director Director Apr 22 Buy 0.9378 75,000 70,335 225,000 04/25/22
AULT MILTON C III Director Director Apr 11 Buy 1.1265 50,000 56,325 150,000 04/12/22
McGrath Lynne Fahey Director Director Mar 28 Sell 1.213 25,000 30,325 75,000 04/08/22
AULT MILTON C III Director Director Mar 18 Buy 1.1045 100,000 110,450 100,000 03/21/22
AULT MILTON C III Director Director Feb 01 Option 0.0004 2,250,000 900 2,500,000 02/01/22
AULT MILTON C III Director Director Jan 27 Buy 1.3950 2,500 3,488 6,977,500 01/28/22
AULT MILTON C III Director Director Jan 24 Buy 1.2899 5,000 6,450 6,975,000 01/25/22
Horne William B. Director Director Jan 24 Option 0.004 150,000 600 250,000 01/25/22
AULT MILTON C III Director Director Jan 18 Buy 1.6599 7,000 11,619 6,970,000 01/19/22
AULT MILTON C III Director Director Jan 14 Buy 1.7894 3,000 5,368 6,963,000 01/18/22
AULT MILTON C III Director Director Jan 07 Buy 1.925 3,000 5,775 6,960,000 01/11/22
AULT MILTON C III Director Director Dec 17 Buy 2.3 38,000 87,400 6,920,388 12/20/21
AULT MILTON C III Director Director Nov 30 Buy 2.13 22,319 47,539 6,907,388 12/02/21
AULT MILTON C III Director Director Nov 22 Buy 1.94 19,681 38,181 6,885,069 11/23/21
AULT MILTON C III Director Director Jul 27 Buy 5.02 12,500 62,750 5,341,555 07/27/21
AULT MILTON C III Director Director Jul 22 Buy 5.33 3,500 18,655 5,329,055 07/22/21